← back to search

Ryan Abo

Ribon Therapeutics (United States) · US
Area of research
Genetics · Cancer Research
Research interest
Research interests include Genetic Associations and Epidemiology, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, and RNA modifications and cancer.
h-index
27
citations
4,603
works
93
NIH funding
primary concept
Biology
email

Recent publications

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Blood 2016cited by 84position: middledoi
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Cancer Research 2016cited by 12position: middledoi
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Blood 2015cited by 597position: middledoi
Arsenic Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Metagenomics and Metabolomics Analysis
Environmental Health Perspectives 2014cited by 517position: middledoi
Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis
Proceedings of the National Academy of Sciences 2014cited by 167position: middledoi
Host plant peptides elicit a transcriptional response to control the <i>Sinorhizobium meliloti</i> cell cycle during symbiosis
Proceedings of the National Academy of Sciences 2014cited by 160position: middledoi
Diverse cell stresses induce unique patterns of tRNA up- and down-regulation: tRNA-seq for quantifying changes in tRNA copy number
Nucleic Acids Research 2014cited by 139position: middledoi
Global analysis of cell cycle gene expression of the legume symbiont<i>Sinorhizobium meliloti</i>
Proceedings of the National Academy of Sciences 2014cited by 85position: middledoi
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment
Cell 2013cited by 924position: middledoi
Gut Microbiome Perturbations Induced by Bacterial Infection Affect Arsenic Biotransformation
Chemical Research in Toxicology 2013cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stuart S. Levine · Massachusetts Institute of Technology3 papers (2013–2014)Katherine Ann Schlieper · Massachusetts Institute of Technology2 papers (2013–2014)Jon Penterman · Massachusetts Institute of Technology2 papers (2014–2014)Michelle E. Graffam · Massachusetts Institute of Technology2 papers (2013–2014)Nicole J. De Nisco · The University of Texas at Dallas2 papers (2014–2014)Steven R. Tannenbaum · Massachusetts Institute of Technology2 papers (2013–2014)John S. Wishnok · Massachusetts Institute of Technology2 papers (2013–2014)Graham C. Walker · Massachusetts Institute of Technology2 papers (2014–2014)Kun Lü · University of North Carolina at Chapel Hill2 papers (2013–2014)James G. Fox · Michigan United2 papers (2013–2014)James A. Swenberg · University of North Carolina at Chapel Hill2 papers (2013–2014)Vincent L. Butty · Massachusetts Institute of Technology2 papers (2013–2014)Connie Wu · Massachusetts Institute of Technology1 papers (2014–2014)Patrizia Mazzucato · Massachusetts Institute of Technology1 papers (2014–2014)Amanda L. Christie · Massachusetts Institute of Technology1 papers (2016–2016)Carla Klattenhoff · Massachusetts Institute of Technology1 papers (2013–2013)Matteo Zanda · University of Aberdeen1 papers (2014–2014)Matthew L. Steinhauser · University of Pittsburgh1 papers (2013–2013)Lauren E. Surface · University of Michigan1 papers (2013–2013)Leona D. Samson · Massachusetts Institute of Technology1 papers (2014–2014)